Engineers Gate Manager LP Sells 201,521 Shares of Teladoc Health, Inc. $TDOC

Key Points

• Engineers Gate Manager LP cut its Teladoc Health stake by 58.7% in the second quarter, selling 201,521 shares and retaining 142,040 shares valued at approximately $1.2 million.
• Institutional investors own 76.82% of Teladoc, while CEO Charles III sold 17,805 shares for about $108,600 to cover tax withholding obligations tied to vested equity awards.
• Analyst sentiment remains mixed, with the stock carrying an overall “Hold” rating and an average price target of $7.54; Teladoc recently reported a quarterly revenue decline of 4% year over year despite exceeding EPS expectations.

Engineers Gate Manager LP trimmed its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 58.7% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 142,040 shares of the health services provider's stock after selling 201,521 shares during the period. Engineers Gate Manager LP owned approximately 0.08% of Teladoc Health worth $1,204,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the business. Allworth Financial LP bought a new position in shares of Teladoc Health during the 2nd quarter valued at $25,000. Twin Lakes Capital Management LLC bought a new stake in shares of Teladoc Health in the second quarter worth $26,000. Nykredit A S bought a new stake in shares of Teladoc Health in the second quarter worth $27,000. EverSource Wealth Advisors LLC increased its position in Teladoc Health by 694.5% during the first quarter. EverSource Wealth Advisors LLC now owns 5,657 shares of the health services provider's stock valued at $31,000 after acquiring an additional 4,945 shares during the last quarter. Finally, EFG International AG purchased a new stake in Teladoc Health during the second quarter valued at $35,000. Hedge funds and other institutional investors own 76.82% of the company's stock.

Insider Activity at Teladoc Health

In other news, CEO Charles III sold 17,805 shares of the firm's stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $6.10, for a total transaction of $108,610.50. Following the transaction, the chief executive officer directly owned 465,535 shares of the company's stock, valued at approximately $2,839,763.50. This trade represents a 3.68% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 0.70% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. Bank of America raised their target price on Teladoc Health from $9.00 to $10.50 and gave the stock a "buy" rating in a research report on Tuesday, July 7th. Citigroup lowered their price objective on shares of Teladoc Health from $11.00 to $7.50 and set a "neutral" rating on the stock in a research note on Monday, August 3rd. Weiss Ratings reissued a "sell (d-)" rating on shares of Teladoc Health in a report on Wednesday, August 19th. Finally, Canaccord Genuity Group reduced their price objective on Teladoc Health from $11.00 to $10.00 and set a "buy" rating for the company in a research note on Thursday, July 30th. Five research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $7.54.

Teladoc Health Trading Up 0.6%

Shares of TDOC opened at $6.32 on Friday. The company's fifty day simple moving average is $7.23 and its 200-day simple moving average is $6.80. The company has a market cap of $1.15 billion, a P/E ratio of -6.38 and a beta of 2.12. Teladoc Health, Inc. has a twelve month low of $4.40 and a twelve month high of $9.89.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The health services provider reported ($0.21) EPS for the quarter, beating the consensus estimate of ($0.25) by $0.04. Teladoc Health had a negative net margin of 7.13% and a negative return on equity of 12.15%. The company had revenue of $606.93 million for the quarter, compared to the consensus estimate of $615.44 million. During the same period in the prior year, the firm posted ($0.19) EPS. The firm's revenue was down 4.0% compared to the same quarter last year. Teladoc Health has set its Q3 2026 guidance at -0.300--0.200 EPS and its FY 2026 guidance at -1.000--0.750 EPS. Analysts predict that Teladoc Health, Inc. will post -0.92 earnings per share for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc is a virtual healthcare company that provides telehealth services and technology to individuals, employers, health plans, health systems and other organizations. Its platform enables patients to connect with healthcare professionals remotely through phone, video and digital tools, supporting access to medical care across a range of specialties.

The company's offerings include general medical consultations, mental health services through BetterHelp, expert medical opinions, chronic condition management and digital health programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.